NGNE - Volume dana dhuwit perusahaan Neurogene

Tandha merek Neurogene Inc. (NGNE)

The cash trajectory demonstrates the financial autonomy of Neurogene Inc. (NGNE), as the success of gene therapy is not tied to market cycles. The 0.36 mark serves as a key metric of business resilience. The company's valuation growth relies on breakthroughs in Rett syndrome treatment and Fast Track designations, while strictly adhering to biosafety protocols in laboratories.

Neurogene Corp - Aset likuid perusahaan NGNE (periode 21.02.2024 - 21.11.2026)

NGNE (Neurogene Inc): rincian analitis lan laporan miturut indikator

- nilai saham lan prakiraan konsensus rega:
Ringkesan analitik perusahaan:Neurogene Inc
Produk merek Neurogene

This indicator reflects the volume of liquid assets in the organization's accounts, determining its current financial stability. By analyzing the company's cash position, an investor assesses the actual capital balance excluding market fluctuations. Liquidity dynamics are critical for controlling operating expenses and preventing resource deficits. For Neurogene Inc. (NGNE), this reserve is vital when navigating the costly stages of FDA clinical trials.

Pesaing Neurogene Inc. (NGNE)

Volume dana dhuwit perusahaan BIIB|Dana dhuwit perusahaan NBIX (Neurocrine Biosciences)|Dana dhuwit perusahaan Regencell Bioscience Ltd RGC|AXSM (Axsome Therapeutics, Inc.) - Total volume dana dhuwit perusahaan|ACADIA Corp - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Xenon Pharmaceuticals|VKTX (Viking Therapeutics Corp) - Dhuwit awis perusahaan|Supernus Pharmaceuticals (SUPN) - Volume dana dhuwit perusahaan|CPRX (Catalyst Pharma) - Volume dana dhuwit perusahaan|DNLI (Denali Therapeutics Inc.) - Gunggung dana dhuwit perusahaan|Volume dana dhuwit perusahaan HRMY|Biohaven Corp - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan AMLX (amylyx.com)|Aset likuid perusahaan Trevi Therapeutics, Inc. (TRVI)|Praxis Corp - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Anavex|CBLL (CeriBell Inc) - Dhuwit awis perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan PRTA|Dana dhuwit perusahaan Alector Inc.|Cadangan dhuwit perusahaan Annexon, Inc. ANNX|Dana dhuwit perusahaan Omeros Corp (OMER)|Aset likuid perusahaan AC Immune S.A.|Volume dana dhuwit perusahaan VYGR (Voyager Therapeutics Inc)|Sisa dhuwit perusahaan NMRA|scilexholding.com - Volume dana dhuwit perusahaan|TVGN (tevogen.com) - Dhuwit awis lan setara dhuwit awis perusahaan|ACOG: Volume dana dhuwit perusahaan|CGTX: Gunggung dana dhuwit perusahaan|Dana dhuwit perusahaan Inhibikase Therapeutics|Dhuwit awis lan setara dhuwit awis perusahaan SAVA (Cassava)|Dana dhuwit perusahaan Assertio Therapeutics (ASRT)|Coya Therapeutics - Dhuwit awis lan setara dhuwit awis perusahaan|VistaGen Therapeutics, Inc. - Dhuwit awis perusahaan|ovidrx.com (OVID) - Cadangan dhuwit perusahaan|ABOS: Dhuwit awis perusahaan|Cadangan dhuwit perusahaan CervoMed Inc|alteritytherapeutics.com (ATHE) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Clene Nanomedicine|Dhuwit awis perusahaan PEPG|Cadangan dhuwit perusahaan Jupiter Neurosciences JUNS|Dana dhuwit perusahaan Relmada (RLMD)|Aset likuid perusahaan Annovis Bio, Inc.|Volume dana dhuwit perusahaan GRCE (Grace Tx)|Firefly Neuroscience, Inc (AIFF) - Cadangan dhuwit perusahaan|KLTO - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan NeuroSense Therapeutics Ltd|RVPH: Volume dana dhuwit perusahaan|MetaVia, Inc. (MTVA) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan NeurAxis|Volume dana dhuwit perusahaan heliusmedical.com|Dhuwit awis perusahaan PASG (Passage Bio Inc.)|Neuphoria Therapeutics - Dhuwit awis lan setara dhuwit awis perusahaan|Minerva Neurosciences Corp - Dhuwit awis perusahaan|Sisa dhuwit perusahaan ATHA|ADXN - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Alzamend Neuro Inc.|Cyclerion Therapeutics (CYCN) - Dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan PTIX|KTTA (pasitheaclinics.com) - Volume dana dhuwit perusahaan|CRGT (cortigent.com) - Gunggung dana dhuwit perusahaan|Volume dana dhuwit perusahaan ATXI|Dana dhuwit perusahaan BCLI (Brainstorm Cell)|Volume dana dhuwit perusahaan CARA (Cara Therapeutics Inc)|Sisa dhuwit perusahaan CHRO|Eliem Therapeutics Inc. - Volume dana dhuwit perusahaan|ITCI - Volume dana dhuwit perusahaan|Longboard Pharma (LBPH) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Marinus Pharmaceuticals|Dana dhuwit perusahaan NKGen|Volume dana dhuwit perusahaan NeuroBo Pharmaceuticals, Inc.|Volume dana dhuwit perusahaan SAGE|Synaptogenix, Inc - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Trevena TRVN|Posisi dhuwit perusahaan Vigil Neuroscience|Anew Medical Inc. - Volume dana dhuwit perusahaan|Aset likuid perusahaan Cerevel Therapeutics, Inc. CERE